Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.00
Bid: 40.00
Ask: 42.00
Change: 0.00 (0.00%)
Spread: 2.00 (5.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 41.00
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Celerum launch first commercial product

11 Jan 2022 07:00

RNS Number : 9908X
Frontier IP Group plc
11 January 2022
 

Reach - a non-regulatory announcement

AIM: FIPP

11 January 2022

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

 

Portfolio news - Celerum reaches significant milestone with launch of first commercial product

 

Frontier IP, a specialist in commercialising intellectual property, notes the following announcement that portfolio company Celerum Limited (the "Company") has launched Truck Logistics System, its first commercial product using novel artificial intelligence based on Nature Inspired Computing.

 

The Company has also won a first order from a road haulier for the software. The product uses artificial intelligence derived from natural processes and behaviours to maximise resources across logistics networks, cutting costs, carbon emissions and delivery times. Frontier IP holds a 33.8 per cent equity stake in Celerum.

 

Neil Crabb, Frontier IP Chief Executive Officer, said: "The launch of its first commercial software is an exciting development for Celerum. The need for companies to maximise the resource efficiency of their supply chains and logistics has been underlined by recent concerns over lorry driver shortages in the UK and the pressing need to minimise carbon emissions as part of initiatives to tackle climate change." 

 

 

Celerum statement begins:

 

 

Celerum launches AI-based Truck Logistics System to maximise efficiencies for small to medium sized fleets

 

 

· Celerum launches Truck Logistics System to cut road haulage costs, carbon emissions and delivery times - making logistics faster, greener and more efficient

 

· Wins first customer for software using the company's novel artificial intelligence based on Nature Inspired Computing

 

Celerum today announces the launch of its first commercially available product based on its novel Nature Inspired Computing (NIC) artificial intelligence to improve the efficiency of supply chains and logistics. The company's Truck Logistics System has also won its first customer.

 

Truck Logistics System is aimed at companies operating small to medium-sized truck fleets, such as road hauliers, suppliers and retailers. Such firms are still typically dependent on manual processes or Excel spreadsheets to organise their operations, lacking the resources to develop the bespoke systems used by bigger companies.

 

Celerum's software is easy to implement. It is cloud based and runs on standard computers with drivers able to interact with the system via their smartphones. It allows controllers to plan more effectively and to manage resources in real time, so they can optimise load capacity, drivers and route selection in response to changing conditions. As a result, they can cut costs and carbon emissions. The first customer is a road haulier operating a fleet of about 75 trucks and 150 trailers in the north of the UK.

 

The technology is based on more than 25 years' research into NIC by Celerum founder and chairman Professor John McCall, Head of Research at the National Subsea Centre at Robert Gordon University, Aberdeen.

Nature Inspired Computing creates algorithms using lessons from the natural world where evolution has overcome inefficiency. For example, bees and ants are extremely good at finding the best routes to food sources or returning to their nests.

 

A pilot project including Celerum organised by Highlands and Islands Enterprise found that NIC-based artificial intelligence cut carbon emissions by up to 40 per cent across food and drink supply chains when allied to behavioural changes such as load sharing between producers and hauliers. A wider ranging follow up project is now being planned.

 

Professor John McCall, Founder and Chairman of Celerum, said: "Truck Logistics System has the potential to transform operational efficiency for hundreds of companies currently running their van and truck fleets using manual processes or spreadsheets. The fact it has already won a customer gives us every hope for further success. However, TLS is only the first commercial application of our NIC-based AI and we are confident it will be able to help solve a host of other supply chain and logistics problems."

 

Celerum statement ends

 

 

 

ENQUIRIES

 

Frontier IP Group Plc

T: 020 7332 2338

Neil Crabb, Chief Executive Officer

Andrew Johnson, Communications and investor relations

andrew.johnson@frontierip.co.uk

Company website: www.frontierip.co.uk

 

 

neil@frontierip.co.uk

M: 07464 546 025

Allenby Capital Limited (Nominated Adviser)

Nick Athanas / George Payne

 

 

 

T: 0203 328 5656

 

 

 

 

ABOUT FRONTIER IP

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

About Reach announcements

 

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

 

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAGZGMMRGLGZZM
Date   Source Headline
2nd May 20247:00 amRNSFrontier IP announces stake in DiaGen
17th Apr 20241:59 pmRNSHolding(s) in Company
12th Apr 20247:00 amRNSAppointment of Chief Financial Officer
2nd Apr 202412:44 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSUnaudited Half Year Results
4th Mar 20241:40 pmRNSHolding(s) in Company
29th Feb 20243:12 pmRNSSale of shares in Exscientia
30th Jan 202411:45 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSOctopus invest in Alusid as part of equity funding
29th Dec 202312:00 pmRNSTotal Voting Rights
19th Dec 20234:46 pmRNSHolding(s) in Company
15th Dec 20236:12 pmRNSReplacement - Result of AGM and Directorate Change
15th Dec 20232:07 pmRNSResult of AGM and Directorate Change
13th Dec 20237:00 amRNSPortfolio news - The Vaccine Group
11th Dec 20237:00 amRNSHolding(s) in Company
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholdings
28th Nov 20237:00 amRNSBoard Change
21st Nov 20237:00 amRNSPosting of Annual Report and Notice of AGM
9th Nov 20235:27 pmRNSHolding(s) in Company
3rd Nov 20237:05 amRNSGrant of options
1st Nov 20235:48 pmRNSExercise of Options & PDMR Shareholdings & TVR
31st Oct 20237:01 amRNSBoard changes
31st Oct 20237:00 amRNSFinal results for the year ended 30 June 2023
23rd Oct 20237:00 amRNSNew portfolio company Deakin Bio-Hybrid Materials
12th Oct 20232:05 pmRNSHolding(s) in Company
21st Sep 20237:00 amRNSExscientia announces collaboration with Merck
14th Sep 20235:21 pmRNSHolding(s) in Company
14th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
11th Sep 20237:00 amRNSPortfolio news – Pulsiv appoints Chairman and CPO
8th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
10th Aug 20238:45 amRNSPortfolio news – Fieldwork Robotics
24th Jul 20237:00 amRNSPortfolio news – CamGraPhIC loan facility
20th Jul 20235:18 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSSale of shares in Exscientia
26th May 20236:06 pmRNSHolding(s) in Company
9th May 20237:00 amRNSTopps Tiles launches first Alusid made tile range
21st Apr 20234:00 pmRNSDirectorate Change
20th Apr 20235:26 pmRNSHolding(s) in Company
27th Mar 20235:17 pmRNSHolding(s) in Company
17th Mar 20232:46 pmRNSGrant of options
15th Mar 20237:00 amRNSBoard changes
15th Mar 20237:00 amRNSUnaudited Half Year Results
30th Jan 20237:00 amRNSAlusid in collaboration with Imerys
9th Jan 20237:00 amRNSCelerum appoints David Gladding as CEO
9th Dec 20224:08 pmRNSResult of AGM
7th Dec 20221:25 pmEQSThe Vaccine Group completes two deadly disease vaccination projects
6th Dec 20227:00 amRNSFrontier IP to host Portfolio Demo Day
5th Dec 20227:00 amRNSThe Vaccine Group completes Lassa fever project
2nd Dec 20227:00 amRNSThe Vaccine Group completes vaccine project

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.